Abstract
Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have